0001613386-21-000001.txt : 20210819 0001613386-21-000001.hdr.sgml : 20210819 20210819135600 ACCESSION NUMBER: 0001613386-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210819 DATE AS OF CHANGE: 20210819 EFFECTIVENESS DATE: 20210819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aminex Therapeutics, Inc. CENTRAL INDEX KEY: 0001613386 IRS NUMBER: 263969765 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-410602 FILM NUMBER: 211189750 BUSINESS ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 BUSINESS PHONE: 425-286-4222 MAIL ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 D 1 primary_doc.xml X0708 D LIVE 0001613386 Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 512-413-8255 WASHINGTON None None Corporation true James Skaggs 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Executive Officer Director Mark Burns 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Executive Officer Director Jeff Miller 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Director Rhonda Rhyne 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Director Stacy Hock 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Director Roger Ulrich 6830 NE Bothell Way Ste. C 139 Kenmore WA WASHINGTON 98028 Director Larry Richards 6830 NE Bothell Way Stc. 139 Kenmore WA WASHINGTON 98028 Executive Officer Biotechnology Decline to Disclose 06b false 2021-08-04 false true false 2 9141549 6298504 2843045 $3,141,549 pursuant to conversion of convertible promissory notes, remaining $3,156.955 issued pursuant to cash investment. false 97 0 0 0 false Aminex Therapeutics, Inc. /s/ James B. Skaggs James B. Skaggs Chief Executive Officer 2021-08-18